<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APA</z:chebi>), including <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (LAC; as detected by in vitro blood clotting tests) and anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies (ACA; as assayed by solid-phase immunoassay), are strongly associated with <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and recurrent fetal loss in some patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>The combined presence of <z:chebi fb="21" ids="53713">APA</z:chebi> and these clinical manifestations is termed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>LAC and ACA comprise <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and somewhat overlapping autoantibody subsets </plain></SENT>
<SENT sid="3" pm="."><plain>To date, it is unclear what degree of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> is present in an individual patient and between patients </plain></SENT>
<SENT sid="4" pm="."><plain>To begin to address these issues, we generated three monoclonal LAC antibodies from a patient with SLE and APS </plain></SENT>
<SENT sid="5" pm="."><plain>These antibodies were studied for their binding specificities and variable (V) region nucleotide sequences </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three LAC were unreactive with DNA, <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> or other <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Sequence analysis of these antibodies revealed extensive overlap in their Ig V genes with anti-DNA antibodies and other autoantibodies characteristic of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These data provide the first V gene sequence information on a group of SLE-derived LAC without ACA activity, representative of a similar subset of LAC found in patients with APS </plain></SENT>
</text></document>